What question did this study set out to answer?

To review the pathophysiology, risk factors, and clinical management strategies for small-for-size syndrome following living donor liver transplantation.

October 29, 2024Updates in SurgeryOpen Access

The small-for-size syndrome in living donor liver transplantation: current management

View Full Paper

Ask AI

Bookmark

Authors

LPLuca Del PreteCleveland Clinic CQCristiano QuintiniCleveland Clinic TUTeresa Diago UsoAbu Dhabi University

Discussion

Member takes

Implication

Review details pathophysiology and management of small-for-size syndrome in living donor liver transplant recipients, indicating how inflow modulation improves outcomes with ultra-small grafts.

Key Points

To review the pathophysiology, risk factors, and clinical management strategies for small-for-size syndrome following living donor liver transplantation.
Narrative synthesis of clinical literature on small-for-size syndrome mechanisms, risk factors, and donor-recipient matching.
Evaluation of intraoperative hemodynamic monitoring, pharmacologic interventions, and surgical portal inflow modulation techniques.
Identifies graft portal hyperperfusion resulting from recipient hyperdynamic circulation and inadequate liver mass as the primary cause of graft dysfunction.
Highlights medical treatments, including somatostatin analogues, beta-blockers, and vasopressin analogues, alongside surgical inflow diversion, to reduce elevated portal pressure.
Demonstrates that combining hemodynamic monitoring with tailored inflow and outflow modulation facilitates graft survival even when utilizing ultra-small liver grafts.

Cite This Study

Prete et al. (2024) studied this question.

synapsesocial.com/papers/6a872891b688e10ffe82ccac https://doi.org/10.1007/s13304-024-01964-7

View Full Paper

Ask AI

Bookmark

October 29, 2024Updates in SurgeryOpen Access

The small-for-size syndrome in living donor liver transplantation: current management

View Full Paper

Ask AI

Bookmark

Authors

LPLuca Del PreteCleveland Clinic CQCristiano QuintiniCleveland Clinic TUTeresa Diago UsoAbu Dhabi University

Discussion

Member takes

Implication

Review details pathophysiology and management of small-for-size syndrome in living donor liver transplant recipients, indicating how inflow modulation improves outcomes with ultra-small grafts.

Key Points

To review the pathophysiology, risk factors, and clinical management strategies for small-for-size syndrome following living donor liver transplantation.
Narrative synthesis of clinical literature on small-for-size syndrome mechanisms, risk factors, and donor-recipient matching.
Evaluation of intraoperative hemodynamic monitoring, pharmacologic interventions, and surgical portal inflow modulation techniques.
Identifies graft portal hyperperfusion resulting from recipient hyperdynamic circulation and inadequate liver mass as the primary cause of graft dysfunction.
Highlights medical treatments, including somatostatin analogues, beta-blockers, and vasopressin analogues, alongside surgical inflow diversion, to reduce elevated portal pressure.
Demonstrates that combining hemodynamic monitoring with tailored inflow and outflow modulation facilitates graft survival even when utilizing ultra-small liver grafts.

Cite This Study

Prete et al. (2024) studied this question.

synapsesocial.com/papers/6a872891b688e10ffe82ccac https://doi.org/10.1007/s13304-024-01964-7

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark